Cc1cc(C)nc(-n2nc(C)c3c2NC(=O)CC3c2cc(F)ccc2F)n1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?